ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

GlaxoSmithKline Buys Back 675,000 Shares

LONDON--GlaxoSmithKline PLC (GSK.LN) said Monday it purchased 675,000 shares. MAIN FACTS: -Highest price paid: 1485 pence per share. -Lowest price paid: 1470.5 pence per share. -Shares to be held in Treasury. -Write to Mark Shapland at [email protected] Subscribe to WSJ:

Stock News for Glaxosmithkline (GSK)
01/17/201708:18:13Report of Foreign Issuer (6-k)
01/17/201707:42:33Report of Foreign Issuer (6-k)
01/17/201706:45:04Report of Foreign Issuer (6-k)
01/17/201706:44:18Report of Foreign Issuer (6-k)
01/17/201706:35:24Report of Foreign Issuer (6-k)
01/17/201706:28:41Report of Foreign Issuer (6-k)
01/13/201713:53:03Report of Foreign Issuer (6-k)
01/13/201713:40:24Report of Foreign Issuer (6-k)
01/13/201711:00:50Report of Foreign Issuer (6-k)
01/12/201713:27:00Report of Foreign Issuer (6-k)
01/10/201717:28:00Mayne Pharma Launches Foam Dermatology Products in US
01/10/201713:19:24Report of Foreign Issuer (6-k)
01/09/201708:01:00Adaptimmune confirms GSK Nomination of Second Adaptimmune Target...
01/03/201706:22:43Report of Foreign Issuer (6-k)
12/20/201611:00:50Report of Foreign Issuer (6-k)
12/20/201607:10:35Report of Foreign Issuer (6-k)
12/20/201607:04:00GlaxoSmithKline's New Drug Challenges HIV Treatment Orthodoxy...
12/20/201606:58:06Report of Foreign Issuer (6-k)
12/20/201605:57:00GlaxoSmithKline's New Drug Challenges AIDS Treatment Orthodoxy
12/19/201611:50:35Report of Foreign Issuer (6-k)

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations